See2Cure

Develops a diagnostic probe for fluorescence-guided surgery, aimed at detecting tumours invisible to the naked eye and preventing relapse of abdominal cancers. Targeting peritoneal metastases from colorectal, gastric, ovarian and pancreatic cancers, this technology enables early and accurate detection of lesions, whether visible during open or minimally invasive surgery, helping to improve surgical outcomes and reduce the risk of recurrence.